Evidence map›Paper›PMID 28210321›Full record

ArticleBreathe (Sheffield, England)2016

Telemedicine in chronic obstructive pulmonary disease.

Nicolino Ambrosino, Guido Vagheggini, Stefano Mazzoleni, Michele Vitacca

Open access · diamondAbstract read
In one paragraph

Article in Breathe (Sheffield, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?American journal of respiratory and critical care medicine · 2025
    Review
  6. Article
  7. Article
  8. Digital health in chronic obstructive pulmonary disease.Chronic diseases and translational medicine · 2023
    Review
  9. Telehealth and telemedicine in the management of adult patients after hospitalization for COPD exacerbation: a scoping review.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A Pervasive Healthcare System for COPD Patients.Diagnostics (Basel, Switzerland) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nicolino AmbrosinoFondazione Volterra Ricerche, Auxilium Vitae, Volterra, Italy.
Guido VaghegginiFondazione Volterra Ricerche, Auxilium Vitae, Volterra, Italy.
Stefano MazzoleniThe Biorobotics Institute, Scuola Superiore Sant'Anna, Pisa, Italy.
Michele VitaccaIstituti Clinici Scientifici Maugeri IRCCS Lumezzane, Lumezzane, Italy.
Istituti Clinici Scientifici Maugeri · ITScuola Superiore Sant'Anna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telemedicine is a medical application of advanced technology to disease management. This modality may provide benefits also to patients with chronic obstructive pulmonary disease (COPD). Different devices and systems are used. The legal problems associated with telemedicine are still controversial. Economic advantages for healthcare systems, though potentially high, are still poorly investigated. A European Respiratory Society Task Force has defined indications, follow-up, equipment, facilities, legal and economic issues of tele-monitoring of COPD patients including those undergoing home mechanical ventilation. KEY POINTS: The costs of care assistance in chronic disease patients are dramatically increasing.Telemedicine may be a very useful application of information and communication technologies in high-quality healthcare services.Many remote health monitoring systems are available, ensuring safety, feasibility, effectiveness, sustainability and flexibility to face different patients' needs.The legal problems associated with telemedicine are still controversial.National and European Union governments should develop guidelines and ethical, legal, regulatory, technical, administrative standards for remote medicine.The economic advantages, if any, of this new approach must be compared to a "gold standard" of homecare that is very variable among different European countries and within each European country.The efficacy of respiratory disease telemedicine projects is promising ( EDUCATIONAL

aimsTo clarify definitions of aspects of telemedicineTo describe different tools of telemedicineTo provide information on the main clinical resultsTo define recommendations and limitations.

Identifiers

PMID28210321
PMCPMC5297949
OpenAlexW2559448330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.